The tumor suppressor RECK interferes with HER-2/Neu dimerization and attenuates its oncogenic signaling

9Citations
Citations of this article
6Readers
Mendeley users who have this article in their library.

Abstract

Our previous study demonstrates that HER-2/Neu oncogene inhibits a matrix metalloproteinase inhibitor and tumor metastasis suppressor RECK to promote metastasis. Conversely, the effect of RECK on the oncogenic function of HER-2/Neu is unknown. Ectopic expression of RECK in 293T cells and HER-2/Neu-overexpressing breast cancer cells shows that RECK and HER-2/Neu are co-localized and these two proteins can be co-immunoprecipitated. RECK inhibits HER-2/Neu receptor dimerization and autophosphorylation, which causes reduction of ERK and AKT kinase activity and down-regulation of HER-2/Neu target genes. RECK expression is reduced in 58.8% of breast cancer tissues and is associated with lymph node invasion supporting its anti-metastatic role. Collectively, we provide the first evidence that RECK can negatively regulate oncogenic activity of HER-2/Neu by inhibiting receptor dimerization. Structured summary: HER-2/Neu physically interacts with HER-2/Neu by blue native page (View interaction) HER-2/Neu physically interacts with RECK by coimmunoprecipitation (View interaction) HER-2/Neu and RECK colocalize by fluorescence microscopy (View Interaction 1, 2) HER-2/Neu physically interacts with RECK by anti bait coimmunoprecipitation (View interaction) © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Cite

CITATION STYLE

APA

Hong, K. J., Hsu, M. C., Hou, M. F., & Hung, W. C. (2011). The tumor suppressor RECK interferes with HER-2/Neu dimerization and attenuates its oncogenic signaling. FEBS Letters, 585(4), 591–595. https://doi.org/10.1016/j.febslet.2011.01.021

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free